Based on guidance methods used in medical institutions, we have developed a unique program, "Rohto Medical Care Method™,"
to improve our customers' cosmetic literacy.
We have also launched a new brand, "Dermacept RX" series, to ensure that functional cosmetics are used correctly and appropriately.
May 11, 2023
ROHTO Pharmaceutical Co., Ltd. (Headquarters: Osaka City, President: Masafumi Sugimoto) has developed a new sales system, "Rohto Medical Care Method," based on the concept of "usage guidance after a consultation" conducted at medical institutions. This system aims to improve cosmetic literacy, enabling customers to use functional cosmetics correctly and appropriately. Furthermore, on May 11, 2023, a new brand, "Dermacept RX" which adopts this program, will be launched through Rohto's online store. This service and product proposal is born from Rohto's long-standing belief in manufacturing: "We want to deliver highly effective products to our customers in a safe and secure state."
Background of the business launch
Our company was founded in 1899 with the launch of the gastrointestinal medicine "Ikatsu." Since starting the sale of skin medications under the Mentholatum brand in 1975, we have continued to sell products such as "Obagi," "Hada Labo," and "MELANO CC," focusing on ingredients and functionality unique to a pharmaceutical company, while conducting continuous research and development. Currently, our Skincare Business accounts for approximately 60% of our sales. Furthermore, since 2005, we have been supporting the beauty and health of patients with the "DRX" skincare brand, exclusively for medical institutions, while managing efficacy and safety in collaboration with dermatologists.
In recent years, with increased customer awareness of beauty, there has been a rise in customers seeking effective ingredients and products that bring about changes in their skin. Cosmetics previously sold exclusively at medical institutions have become more accessible, making it easier to obtain more effective products. However, there is also a risk of causing skin problems if these products are used without a proper understanding of the characteristics and risks of each ingredient.
Leveraging the knowledge we have cultivated through our research and development of functional ingredients and collaborations with dermatologists, we aim to improve the cosmetic literacy of each individual by offering suggestions on how to use our products correctly and appropriately for customers seeking effective results.
About our proprietary program, "Rohto Medical Care Method"
The "Rohto Medical Care Method" is our unique system, developed under the supervision of the Japan Society for Aesthetic Dermatology, and is based on the "consultation → usage instruction" approach used in medical institutions.
-
- "Self-skin check and effective usage" that customers can practice themselves.
-
Because our products are effective, we've taken steps to ensure they are used correctly. We recommend completing a self-check sheet and conducting a user test before purchase. Furthermore, based on the characteristics of the ingredients and the skin cycle, we recommend incorporating rest periods (intervals) before using moisturizing and UV protection products.
-
- A dedicated counselor to sincerely address the needs of each customer and their skin.
-
Our counselors, who have received special training, will provide support. We will answer your questions via the "Dermacept RX Dedicated Consultation Hotline."
-
- To improve our customers' cosmetic literacy, we "deliver accurate and useful knowledge."
-
We provide accurate information about skincare and ingredients. We also have a booklet available that includes detailed usage instructions and precautions.
Our thoughts on "Rohto Medical Care Method" and "Dermacept RX"
Product & Brand Marketing Department
Deputy Director: Kuniko Okuno
Up until now, we have addressed skin conditions through dermatological medications and offered preventative measures against skin problems through cosmetics and other skincare products. However, some customers still have persistent skin concerns such as acne and blemishes that cannot be fully resolved by these methods alone.
We believe that being able to offer cosmetic options comparable to those found in medical institutions contributes to our customers' own well-being.
Furthermore, as access to cosmetic dermatology clinics has decreased and the risk of skin problems has increased due to online sales without consultations, we have taken on a new challenge: by replicating proper guidance online under the supervision of doctors, we have created a system that allows for the appropriate use of highly functional ingredients that are only available in medical institutions.
By improving skin literacy among our customers and society at large, we aim to create a society where each individual can choose the right information, use skincare products correctly, and make their own skin healthy and beautiful.
Supervised by: Japan Society for Aesthetic Dermatology
As online shopping becomes commonplace in our lives, functional cosmetics are no exception. However, some products, if not used properly, can not only fail to produce the desired results but also cause side effects, which is why they are handled by medical institutions. There are stores and online shops where these products can be easily purchased, and online resale among customers is also common. These are not safe at all, as there is a risk that the usage instructions cannot be checked and the products may not be stored in proper conditions. That is why we believe it is important to improve cosmetic literacy so that everyone who purchases cosmetics can choose them with the correct information.
About the NPO Japan Society for Aesthetic Dermatology
This research group aims to foster a healthier beauty market by linking beauty and medicine. They conduct educational seminars for healthcare professionals such as doctors, dentists, nurses, and pharmacists, as well as for beauticians, barbers, estheticians, and general consumers.
Rohto Pharmaceutical's commitment to "effectiveness" in its skincare cosmetics manufacturing.
In Skincare Business, since its inception, we have been committed to creating products that prioritize effectiveness, a principle unique to a pharmaceutical company. Approaching the biological functions of the skin with a medical perspective, we have developed "cosmeceuticals"—functional cosmetics that maximize the potential of functional ingredients—by exploring ingredients such as vitamin C, hyaluronic acid, and ceramides, and incorporating our own unique technologies. Furthermore, by establishing a system that integrates basic research, manufacturing, and production, we are able to respond to customer needs more quickly.
Furthermore, by applying our cell-handling technology and engaging in new businesses such as Regenerative medicine, we are developing products with a fresh perspective by combining our over 110 years of eye research, skin cell research, and Regenerative medicine. We will continue to pursue safer, more reliable products with superior skin benefits. This announcement is the first in a series of announcements we will be making regarding our Skincare Business, which we call "Rohto Skin Science," so please look forward to them.
"Dermacept RX Stem Advance" - a product sold exclusively at medical institutions.
As another pillar of the "Dermacept RX" series, we will launch cosmetics containing stem cell culture supernatant *3, utilizing our expertise in Regenerative medicine research, exclusively for sale at medical institutions. Through skincare products developed by our company, which is also involved in cosmetic medicine and Regenerative medicine, we will work together with medical institutions to contribute to the beauty and health of our customers and patients.
*3: Hydrolyzed stem cell acclimatization culture solution (moisturizing ingredient)
| Product name |
Dermacept RX Stem Advance Serum |
Dermacept RX Stem Advance Mask
(Dermacept RX Stem Advance C <Cream Mask> + Dermacept RX Stem Advance M <Mask>) |
| image |
 |
 |
| classification |
cosmetics |
cosmetics |
| Capacity and price |
30mL - ¥38,500 (tax included) |
Two uses - ¥13,200 (tax included) |
- "Dermacept RX" is a registered trademark of ROHTO Pharmaceutical Co., Ltd., Ltd.
- "Stem Advance" is a registered trademark of ROHTO Pharmaceutical Co., Ltd.
- "Rohto Medical Care Method" is a trademark used by ROHTO Pharmaceutical Co., Ltd.